TrialThe lancet. Gastroenterology & hepatology2018

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.

Philip Noel Newsome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.